{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:07:10Z","timestamp":1792220830602,"version":"4.4.0"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Glycyrrhizin preparations (GLPS), derived from Glycyrrhiza uralensis (licorice), are widely used hepatoprotective agents in clinical practice. Their primary active components, 18\u03b1- and 18\u03b2-glycyrrhetinic acid (GA), are represented by formulations including diammonium glycyrrhizinate (DG), compound glycyrrhizin (CG), and magnesium isoglycyrrhizinate (MgIG). This review provides a comprehensive overview of the pharmacokinetic properties of GLPS and their multi-target pharmacological mechanisms, comprising anti-inflammatory, membrane-stabilizing, antioxidant, anti-apoptotic, immunomodulatory, and anti-fibrotic effects that collectively underpin their hepatoprotective activity. We critically evaluate clinical evidence across major liver diseases, including viral hepatitis, drug-induced liver injury, alcoholic liver disease, non-alcoholic fatty liver disease, and autoimmune hepatitis, while highlighting heterogeneity in study designs, geographical concentration of evidence, and the predominance of positive findings that may reflect publication bias. Safety considerations, particularly the risk of pseudoaldosteronism and potential drug interactions, are also discussed. Finally, we outline future research directions, emphasizing the need for large-scale, multicenter randomized controlled trials with standardized outcomes to establish more robust evidence base and support broader international clinical adoption.<\/jats:p>","DOI":"10.3389\/fphar.2026.1795174","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:25:27Z","timestamp":1777523127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Glycyrrhizin preparations in liver diseases: a narrative review of mechanisms and therapeutic potential"],"prefix":"10.3389","volume":"17","author":[{"given":"Tianyu","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiao","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuojie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianya","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linmei","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]},{"name":"Department of Hepatology Division 2, Peking University Ditan Teaching Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.53350\/pjmhs202317615","volume-title":"Comparison of efficacy of glycyrrhiza glabra (licorice extract) and vitamin E in decreasing fibrosis score in patients with non-alcoholic fatty liver disease","author":"Abdullah","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1248\/bpb.23.149","article-title":"Competition in the metabolism of glycyrrhizin with glycyrrhetic acid mono-glucuronide by mixed Eubacterium sp. GLH and Ruminococcus sp. PO1-3","volume":"23","author":"Akao","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/(sici)1097-0142(19970415)79:8<1494::aid-cncr8>3.0.co;2-b","article-title":"The long term efficacy of glycyrrhizin in chronic hepatitis C patients","volume":"79","author":"Arase","year":"1997","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1142\/S0192415X23500209","article-title":"Efficacy and safety of glycyrrhizic acid in treatment of autoimmune hepatitis","volume":"51","author":"Bi","year":"2023","journal-title":"Am. J. Chin. Med."},{"key":"B5","first-page":"403","article-title":"A meta-analysis of efficacy and safety of compound glycyrrhizin combined with tripterygium wilfordii polyglycosides in treating psoriasis","author":"Bing","year":"2021","journal-title":"Int. J. Traditional Chin. Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/mi.2009.130","article-title":"Intranasally delivered siRNA targeting PI3K\/Akt\/mTOR inflammatory pathways protects from aspergillosis","volume":"3","author":"Bonifazi","year":"2010","journal-title":"Mucosal Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fphar.2019.00119","article-title":"Protective effects of magnesium glycyrrhizinate on methotrexate-induced hepatotoxicity and intestinal toxicity May be by reducing COX-2","volume":"10","author":"Cao","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"119895","DOI":"10.1016\/j.jep.2025.119895","article-title":"Glycyrrhizic acid promotes liver regeneration through activating \u03b2-catenin in acetaminophen-induced liver injury","volume":"349","author":"Cao","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.3390\/nu15183866","article-title":"Liquorice toxicity: a comprehensive narrative review","volume":"15","author":"Ceccuzzi","year":"2023","journal-title":"Nutrients"},{"key":"B10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/ijms20020298","article-title":"Homeostasis of glucose and lipid in non-alcoholic fatty liver disease","volume":"20","author":"Chao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1189\/jlb.0404242","article-title":"Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14-and TNF-dependent mechanisms","volume":"76","author":"Chen","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"B12","first-page":"130","article-title":"Chemistry and biological activity of glycyrrhizin","author":"Chen","year":"2007","journal-title":"Zhejiang J. Integr. Tradit. Chin. West Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1021\/jf405352g","article-title":"Glycyrrhetinic acid suppressed NF-\u03baB activation in TNF-\u03b1-induced hepatocytes","volume":"62","author":"Chen","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1515\/med-2018-0010","article-title":"Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China","volume":"13","author":"Chen","year":"2018","journal-title":"Open Med. (Wars)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.2174\/0929867325666191011115407","article-title":"Advances in pharmacological activities and mechanisms of glycyrrhizic acid","volume":"27","author":"Chen","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/jpp\/rgab125","article-title":"Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A","volume":"73","author":"Chen","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2299597","DOI":"10.1080\/09546634.2023.2299597","article-title":"A systematic review and meta-analysis of efficacy and safety of compound glycyrrhizin combined with second-generation non-sedated antihistamine for the treatment of chronic urticaria","volume":"35","author":"Chen","year":"2024","journal-title":"J. Dermatol. Treat."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e81773","DOI":"10.1371\/journal.pone.0081773","article-title":"Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K\/Akt\/mTOR\/HIF-1 alpha\/VEGF pathway","volume":"8","author":"Choi","year":"2013","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the intestinal microbiome and gut barrier to hepatic disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"173258","DOI":"10.1016\/j.ejphar.2020.173258","article-title":"Combination of monoammonium glycyrrhizinate and cysteine hydrochloride ameliorated lipopolysaccharide\/galactosamine-induced acute liver injury through Nrf2\/ARE pathway","volume":"882","author":"Chu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/s0140-6736(03)13615-x","article-title":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus","volume":"361","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/foods8100495","article-title":"Bioactive candy: effects of licorice on the cardiovascular System","volume":"8","author":"Deutch","year":"2019","journal-title":"Foods"},{"key":"B23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4065\/78.6.767","article-title":"Licorice consumption causing severe hypokalemic paralysis","volume":"78","author":"Elinav","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1365-2796.1999.00476.x","article-title":"Life-threatening ventricular tachycardia due to liquorice-induced hypokalaemia","volume":"245","author":"Eriksson","year":"1999","journal-title":"J. Intern Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"794319","DOI":"10.3389\/fphar.2021.794319","article-title":"Magnesium isoglycyrrhizinate ameliorates Concanavalin A-Induced liver injury by inhibiting autophagy","volume":"12","author":"Fan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B26","first-page":"529","article-title":"Clinical Study on the efficacy of Wuzhi Capsule combined with compound glycyrrhizin in the treatment of patients with Nonalcoholic steatohepatitis","volume":"28","author":"Gao","year":"2025","journal-title":"J. Pract. Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"154883","DOI":"10.1016\/j.phymed.2023.154883","article-title":"Comparative effectiveness of glycyrrhizic acid preparations aimed at improving liver function of patients with chronic hepatitis B: a network meta-analysis of 53 randomized controlled trials","volume":"116","author":"Gao","year":"2023","journal-title":"Phytomedicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.17116\/dokgastro20251403171","article-title":"Combination of ursodeoxycholic acid and glycyrrhizic acid (Phosphogliv URSO) in the treatment of nonalcoholic fatty liver disease: results of a multicenter randomized clinical trial on efficacy and safety","volume":"14","author":"Geivandova","year":"2025","journal-title":"Russ. J. Evidence-Based Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1002\/ptr.8288","article-title":"Licorice and liver function in patients with primary liver disease: a systematic review and meta-analysis of RCTs","volume":"38","author":"Giangrandi","year":"2024","journal-title":"Phytother. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/ph15091130","article-title":"Magnesium isoglycyrrhizinate attenuates anti-tuberculosis drug-induced liver injury by enhancing intestinal barrier function and inhibiting the LPS\/TLRs\/NF-\u03baB signaling pathway in mice","volume":"15","author":"Gong","year":"","journal-title":"Pharm. (Basel)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"153942","DOI":"10.1016\/j.phymed.2022.153942","article-title":"Comparative effectiveness of glycyrrhizic acid preparations aimed at preventing and treating anti-tuberculosis drug-induced liver injury: a network meta-analysis of 97 randomized controlled trials","volume":"98","author":"Gong","year":"","journal-title":"Phytomedicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"154587","DOI":"10.1016\/j.phymed.2022.154587","article-title":"Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-\u03b3\/STAT1\/Smad7 pathway","volume":"112","author":"Guo","year":"2023","journal-title":"Phytomedicine"},{"key":"B33","first-page":"1607","article-title":"Observation on the efficacy of Compound glycyrrhizin combined with ligustrazine in the treatment of alcoholic liver disease","volume":"29","author":"Han","year":"2024","journal-title":"J. Nanjing Med. Univ."},{"key":"B34","doi-asserted-by":"publisher","first-page":"107795","DOI":"10.1016\/j.toxicon.2024.107795","article-title":"Hepatoprotective effect of diammonium glycyrrhizinate and neuroprotective effect of piperazine ferulate on AmB-induced liver and kidney injury by suppressing apoptosis in vitro and in vivo","volume":"246","author":"He","year":"2024","journal-title":"Toxicon"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e40285","DOI":"10.17795\/jjnpp-40285","article-title":"Comparison of the in vitro antifibrogenic effects of silymarin, silybin A and 18\u03b1-Glycyrrhizin on activated hepatic stellate cells","volume":"12","author":"Hosseini","year":"2016","journal-title":"Jundishapur J. Nat. Pharm. Prod."},{"key":"B37","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.phymed.2015.05.053","article-title":"Glycyrrhizin, silymarin, and ursodeoxycholic acid regulate a common hepatoprotective pathway in HepG2 cells","volume":"22","author":"Hsiang","year":"2015","journal-title":"Phytomedicine"},{"key":"B38","first-page":"1067","article-title":"Clinical efficacy of puerarin combined with compound ammonium glycyrrhetate S in treatment of alcoholic hepatitis","volume":"30","author":"HuiChun","year":"2014","journal-title":"J. Clin. Hepatology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1136\/gutjnl-2021-325065","article-title":"Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGF\u03b2 signalling","volume":"71","author":"Hung","year":"2022","journal-title":"Gut"},{"key":"B40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3892\/etm.2019.7572","article-title":"Optimal ratio of 18\u03b1- and 18\u03b2-glycyrrhizic acid for preventing alcoholic hepatitis in rats","volume":"18","author":"Huo","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10620-006-3177-0","article-title":"A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients","volume":"51","author":"Ikeda","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/jjco\/hyaf017","article-title":"Systemic therapy for hepatocellular carcinoma, from the early to the advanced stage: a Japanese perspective","volume":"55","author":"Ikeda","year":"2025","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.1111\/jcmm.15230","article-title":"Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis","volume":"24","author":"Jiang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jcem.80.6.7775643","article-title":"3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism","volume":"80","author":"Kato","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0014-2999(01)01424-8","article-title":"Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors","volume":"431","author":"Kimura","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000048283","article-title":"Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma","volume":"62","author":"Kumada","year":"2002","journal-title":"Oncology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0039-128x(90)90024-6","article-title":"The effects of the licorice derivative, glycyrrhetinic acid, on hepatic 3 alpha- and 3 beta-hydroxysteroid dehydrogenases and 5 alpha- and 5 beta-reductase pathways of metabolism of aldosterone in male rats","volume":"55","author":"Latif","year":"1990","journal-title":"Steroids"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.lfs.2007.02.003","article-title":"Glycyrrhizin protection against 3-morpholinosydnonime-induced mitochondrial dysfunction and cell death in lung epithelial cells","volume":"80","author":"Lee","year":"2007","journal-title":"Life Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s12272-014-0526-y","article-title":"Two minor chalcone acetylglycosides from the roots extract of Glycyrrhiza uralensis","volume":"38","author":"Lee","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.19939\/j.cnki.1672-2809.2025.05.18","article-title":"Analysis of efficacy and liver function indices of diammonium glycyrrhizinate combined with Entecavir in the treatment of chronic hepatitis B","volume":"22","author":"Li","year":"2025","journal-title":"Drug Eval."},{"key":"B52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"806249","DOI":"10.3389\/fphar.2021.806249","article-title":"Pharmacotherapies for drug-induced liver injury: a Current literature review","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/jpp\/rgab180","article-title":"Combination of monoammonium glycyrrhizinate and cysteine hydrochloride protects mice against acetaminophen-induced liver injury via Keap1\/Nrf2\/ARE pathway","volume":"74","author":"Li","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e36538","DOI":"10.1097\/MD.0000000000036538","article-title":"Network meta-analysis of different liver protective drugs in the treatment of drug-induced liver injury","volume":"102","author":"Li","year":"2023","journal-title":"Med. Baltim."},{"key":"B56","doi-asserted-by":"publisher","first-page":"101355","DOI":"10.1016\/j.jcmgh.2024.05.003","article-title":"Interplay between drug-induced liver injury and Gut Microbiota: a comprehensive overview","volume":"18","author":"Li","year":"","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bsheal.2024.04.004","article-title":"Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosis","volume":"6","author":"Li","year":"","journal-title":"Biosaf. Health"},{"key":"B58","doi-asserted-by":"publisher","first-page":"115405","DOI":"10.1016\/j.fct.2025.115405","article-title":"Glycyrrhizic acid alleviates gefitinib-induced liver injury by regulating the p53\/p21 pathway and releasing cell cycle arrest","volume":"200","author":"Li","year":"2025","journal-title":"Food Chem. Toxicol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"115466","DOI":"10.1016\/j.colsurfb.2026.115466","article-title":"Naringenin nanosuspensions embedded glycyrrhizin-based hydrogel ameliorates cholestatic liver injury in mice by inhibiting oxidative stress and HMGB1-mediated inflammation","volume":"261","author":"Li","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.3748\/wjg.v21.i17.5271","article-title":"Glycyrrhizic acid inhibits apoptosis and fibrjosis in carbon-tetrachloride-induced rat liver injury","volume":"21","author":"Liang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"100772","DOI":"10.1016\/j.imr.2021.100772","article-title":"Compound glycyrrhizin injection for improving liver function in children with acute icteric hepatitis: a systematic review and meta-analysis","volume":"11","author":"Liang","year":"2022","journal-title":"Integr. Med. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3892\/mmr.2013.1316","article-title":"Mechanism of chronic dietary iron overload-induced liver damage in mice","volume":"7","author":"Liu","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3892\/mmr.2021.12077","article-title":"Exploration of the hepatoprotective effect and mechanism of magnesium isoglycyrrhizinate in mice with arsenic trioxide-induced acute liver injury","volume":"23","author":"Liu","year":"","journal-title":"Mol. Med. Rep."},{"key":"B64","first-page":"5","article-title":"Case report and analysis of severe hypokalemia induced by glycyrrhizic acid preparations","volume":"23","author":"Liu","year":"","journal-title":"China Med. Guide"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2174\/1381612828666220421134910","article-title":"Diammonium glycyrrhizinate preparation for liver function recovery in chronic hepatitis B in China: a meta-analysis with trial sequential analysis","volume":"28","author":"Liu","year":"","journal-title":"Curr. Pharm. Des."},{"key":"B66","doi-asserted-by":"publisher","first-page":"9357","DOI":"10.1080\/21655979.2022.2054224","article-title":"Guizhi Fuling pill attenuates liver fibrosis in vitro and in vivo via inhibiting TGF-\u03b21\/Smad2\/3 and activating IFN-\u03b3\/Smad7 signaling pathways","volume":"13","author":"Liu","year":"","journal-title":"Bioengineered"},{"key":"B67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7150\/ijbs.65402","article-title":"RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism","volume":"18","author":"Liu","year":"","journal-title":"Int. J. Biol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"156216","DOI":"10.1016\/j.phymed.2024.156216","article-title":"Diammonium glycyrrhizinate alleviates iron overload-induced liver injury in mice via regulating the gut-liver axis","volume":"135","author":"Liu","year":"","journal-title":"Phytomedicine"},{"key":"B69","first-page":"230","article-title":"Mechanistic Study of glycyrrhizic acid improving alcoholic fatty liver disease by modulating the SHP1\/SYK signaling pathway in macrophages","volume":"30","author":"Liu","year":"","journal-title":"Altern. Ther. Health Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"155586","DOI":"10.1016\/j.phymed.2024.155586","article-title":"Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages","volume":"133","author":"Lu","year":"2024","journal-title":"Phytomedicine"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2002874","DOI":"10.1002\/advs.202002874","article-title":"OTUD1 activates caspase-independent and caspase-dependent apoptosis by promoting AIF nuclear translocation and MCL1 degradation","volume":"8","author":"Luo","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s11095-013-0986-7","article-title":"Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance","volume":"30","author":"Ma","year":"2013","journal-title":"Pharm. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","article-title":"Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance","volume":"73","author":"Mak","year":"2020","journal-title":"J. Hepatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1124\/dmd.108.021089","article-title":"Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury","volume":"36","author":"Makino","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"B75","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2893.2011.01579.x","article-title":"Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks","volume":"19","author":"Manns","year":"2012","journal-title":"J. Viral Hepat."},{"key":"B76","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3937\/kampomed.66.197","article-title":"Relationship between incidence of pseudoaldosteronism and daily dose of glycyrrhiza: review of the literature","volume":"66","author":"Mantani","year":"2015","journal-title":"Kampo Med."},{"key":"B77","first-page":"138","article-title":"Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial","volume":"12","author":"Marjani","year":"2019","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"B78","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.steroids.2006.01.005","article-title":"Effect of licorice on PTH levels in healthy women","volume":"71","author":"Mattarello","year":"2006","journal-title":"Steroids"},{"key":"B79","doi-asserted-by":"publisher","first-page":"596","DOI":"10.4254\/wjh.v12.i9.596","article-title":"N-acetylcysteine and glycyrrhizin combination: benefit outcome in a murine model of acetaminophen-induced liver failure","volume":"12","author":"Minsart","year":"2020","journal-title":"World J. Hepatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"a022095","DOI":"10.1101\/cshperspect.a022095","article-title":"Regulation of TGF-\u03b2 family signaling by inhibitory smads","volume":"9","author":"Miyazawa","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF00118193","article-title":"Enzyme leakage due to change of membrane permeability of primary cultured rat hepatocytes treated with various hepatotoxins and its prevention by glycyrrhizin","volume":"1","author":"Nakamura","year":"1985","journal-title":"Cell Biol. Toxicol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.lfs.2007.01.033","article-title":"A possible involvement of 3-monoglucuronyl-glycyrrhetinic acid, a metabolite of glycyrrhizin (GL), in GL-induced pseudoaldosteronism","volume":"80","author":"Ohtake","year":"2007","journal-title":"Life Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/anec.12076","article-title":"Licorice-induced severe hypokalemia with recurrent torsade de pointes","volume":"18","author":"Panduranga","year":"2013","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/ptr.6178","article-title":"Liquorice (Glycyrrhiza glabra): a phytochemical and pharmacological review","volume":"32","author":"Pastorino","year":"2018","journal-title":"Phytother. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1021\/acsbiomaterials.5c00004","article-title":"Advanced strategies in enhancing the hepatoprotective efficacy of natural products: integrating nanotechnology, genomics, and mechanistic insights","volume":"11","author":"Patel","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"B86","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1081\/dmr-100104400","article-title":"The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling","volume":"33","author":"Ploeger","year":"2001","journal-title":"Drug Metab. Rev."},{"key":"B88","first-page":"2402","article-title":"Mechanisms of licorice-induced hypertension and implications for clinical practice","volume":"26","author":"Ravi","year":"2020","journal-title":"Med. Recapitul"},{"key":"B89","doi-asserted-by":"publisher","first-page":"Br24","DOI":"10.12659\/msm.882196","article-title":"18\u03b1-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells","volume":"18","author":"Qu","year":"2012","journal-title":"Med. Sci. Monit."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e0458","DOI":"10.1097\/HC9.0000000000000458","article-title":"Autoimmune hepatitis: current and future therapies","volume":"8","author":"Reau","year":"2024","journal-title":"Hepatol. Commun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"6699560","DOI":"10.1155\/2021\/6699560","article-title":"Exploring the pivotal immunomodulatory and anti-inflammatory potentials of glycyrrhizic and glycyrrhetinic acids","volume":"2021","author":"Richard","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"B92","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bsheal.2024.01.002","article-title":"Current epidemiologic features and health dynamics of ESBL-producing Escherichia coli in China","volume":"6","author":"Salman","year":"2024","journal-title":"Biosaf. Health"},{"key":"B93","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000069334","article-title":"Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients","volume":"70","author":"Sasaki","year":"2002","journal-title":"Pathobiology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ijpharm.2019.01.047","article-title":"Glycyrrhizic acid as a multifunctional drug carrier - from physicochemical properties to biomedical applications: a modern insight on the ancient drug","volume":"559","author":"Selyutina","year":"2019","journal-title":"Int. J. Pharm."},{"key":"B95","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3109\/10717544.2014.919544","article-title":"Influence of glycyrrhizin on permeability and elasticity of cell membrane: perspectives for drugs delivery","volume":"23","author":"Selyutina","year":"","journal-title":"Drug Deliv."},{"key":"B96","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.colsurfb.2016.08.037","article-title":"Spectroscopic and molecular dynamics characterization of glycyrrhizin membrane-modifying activity","volume":"147","author":"Selyutina","year":"","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B97","doi-asserted-by":"publisher","first-page":"7122","DOI":"10.26355\/eurrev_202006_21706","article-title":"Glycyrrhizin improves inflammation and apoptosis via suppressing HMGB1 and PI3K\/mTOR pathway in lipopolysaccharide-induced acute liver injury","volume":"24","author":"Shen","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"106578","DOI":"10.1016\/j.intimp.2020.106578","article-title":"Glycyrrhetinic acid alleviates hepatic inflammation injury in viral hepatitis disease via a HMGB1-TLR4 signaling pathway","volume":"84","author":"Shi","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"173167","DOI":"10.1016\/j.ejphar.2020.173167","article-title":"Glycyrrhetinic acid attenuates disturbed vitamin a metabolism in non-alcoholic fatty liver disease through AKR1B10","volume":"883","author":"Shi","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"822154","DOI":"10.3389\/fphar.2021.822154","article-title":"Transcriptome and lipid Metabolomics-Based discovery: Glycyrrhizic acid alleviates tripterygium glycoside tablet-induced acute liver injury by regulating the activities of CYP and the metabolism of phosphoglycerides","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/ptr.5654","article-title":"Oxidative inactivation of liver Mitochondria in high fructose diet-induced metabolic syndrome in rats: effect of Glycyrrhizin treatment","volume":"30","author":"Sil","year":"2016","journal-title":"Phytother. Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fphys.2015.00363","article-title":"Drug-Induced liver toxicity and prevention by herbal antioxidants: an overview","volume":"6","author":"Singh","year":"2015","journal-title":"Front. Physiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.antiviral.2009.10.014","article-title":"Antiviral effect of diammonium glycyrrhizinate and lithium chloride on cell infection by pseudorabies herpesvirus","volume":"85","author":"Sui","year":"2010","journal-title":"Antivir. Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2017.04.021","article-title":"Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice","volume":"806","author":"Sun","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.21037\/apm-20-1971","article-title":"A narrative review of COVID-19: magnesium isoglycyrrhizinate as a potential adjuvant treatment","volume":"10","author":"Tang","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","article-title":"Autoimmmune hepatitis","volume":"19","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/00042737-199910000-00002","article-title":"Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients","volume":"11","author":"Tsubota","year":"1999","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.biopha.2014.06.001","article-title":"Glutathione and redox signaling in substance abuse","volume":"68","author":"Uys","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"B109","first-page":"146","article-title":"Severe hypokalaemic paralysis and rhabdomyolysis due to ingestion of liquorice","volume":"63","author":"van den Bosch","year":"2005","journal-title":"Neth J. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1111\/j.1572-0241.2001.04049.x","article-title":"Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C","volume":"96","author":"van Rossum","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"B111","first-page":"85","article-title":"Clinical analysis of compound glycyrrhizin in the treatment of anti-tuberculosis drug-induced hepatitis","volume":"14","author":"Wang","year":"2012","journal-title":"Chin. Community Dr."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1039\/c6fo00773b","article-title":"Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice","volume":"7","author":"Wang","year":"2016","journal-title":"Food Funct."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/liv.14204","article-title":"Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug-induced liver injury: a phase II trial","volume":"39","author":"Wang","year":"2019","journal-title":"Liver Int."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/metabo12111128","article-title":"Glycyrrhizic acid mitigates tripterygium-glycoside-tablet-induced acute liver injury via PKM2 regulated oxidative stress","volume":"12","author":"Wang","year":"","journal-title":"Metabolites"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/apt.16902","article-title":"Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial","volume":"55","author":"Wang","year":"","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B116","doi-asserted-by":"publisher","first-page":"121110","DOI":"10.1016\/j.lfs.2022.121110","article-title":"Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet","volume":"310","author":"Wang","year":"","journal-title":"Life Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"e0171722","DOI":"10.1128\/spectrum.01717-22","article-title":"Multi-Omics analysis reveals the protection of gasdermin D in Concanavalin A-Induced autoimmune hepatitis","volume":"10","author":"Wang","year":"","journal-title":"Microbiol. Spectr."},{"key":"B118","doi-asserted-by":"publisher","first-page":"113374","DOI":"10.1016\/j.intimp.2024.113374","article-title":"Diammonium glycyrrhizinate ameliorates alcohol-induced liver injury by reducing oxidative stress, steatosis, and inflammation","volume":"143","author":"Wang","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"155878","DOI":"10.1016\/j.phymed.2024.155878","article-title":"Glycyrrhizic acid ameliorates hepatic fibrosis by inhibiting oxidative stress via AKR7A2","volume":"133","author":"Wang","year":"","journal-title":"Phytomedicine"},{"key":"B120","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1142\/S0192415X25500120","article-title":"Ameliorative effect of glycyrrhizic acid on Diosbulbin B-Induced liver injury and its mechanism","volume":"53","author":"Wang","year":"2025","journal-title":"Am. J. Chin. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1080\/13880209.2021.1973039","article-title":"Efficiency and safety of desloratadine in combination with compound glycyrrhizin in the treatment of chronic urticaria: a meta-analysis and systematic review of randomised controlled trials","volume":"59","author":"Wen","year":"2021","journal-title":"Pharm. Biol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"13498","DOI":"10.1038\/ncomms13498","article-title":"CUG-binding protein 1 regulates HSC activation and liver fibrogenesis","volume":"7","author":"Wu","year":"2016","journal-title":"Nat. Commun."},{"key":"B123","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41419-021-03768-8","article-title":"Prevention of D-GalN\/LPS-induced ALI by 18\u03b2-glycyrrhetinic acid through PXR-mediated inhibition of autophagy degradation","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"tfaf024","DOI":"10.1093\/toxres\/tfaf024","article-title":"Magnesium isoglycyrrhizinate prevented the liver injury of acetaminophen by promoting mitochondrial biogenesis","volume":"14","author":"Xia","year":"2025","journal-title":"Toxicol. Res. (Camb)"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S1875-5364(24)60685-0","article-title":"Glycyrrhizic acid-based multifunctional nanoplatform for tumor microenvironment regulation","volume":"22","author":"Xiao","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s10753-015-0140-2","article-title":"Anti-inflammatory activity of magnesium isoglycyrrhizinate through inhibition of phospholipase A2\/Arachidonic acid pathway","volume":"38","author":"Xie","year":"2015","journal-title":"Inflammation"},{"key":"B127","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1007\/s00216-016-9533-9","article-title":"Development and application of a comprehensive lipidomic analysis to investigate tripterygium wilfordii-induced liver injury","volume":"408","author":"Xie","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"107897","DOI":"10.1016\/j.intimp.2021.107897","article-title":"Patchouli alcohol ameliorates acute liver injury via inhibiting oxidative stress and gut-origin LPS leakage in rats","volume":"98","author":"Xu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/pharmaceutics17010090","article-title":"Glycyrrhizinate monoammonium cysteine-loaded lipid nanoparticles allow for improved acute liver injury therapy","volume":"17","author":"Xu","year":"2025","journal-title":"Pharmaceutics"},{"key":"B130","volume-title":"Pseudoaldosteronism complicated with hypokalemic rhabdomyolysis induced by longterm use of oral glycyrrhizic acid preparations Journal of Adverse Drug Reactions","author":"Xue","year":"2021"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.biopha.2017.01.130","article-title":"Inhibition of PI3K\/AKT\/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis","volume":"89","author":"Xue","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B132","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1124\/dmd.116.069419","article-title":"Glycyrrhizin protects against acetaminophen-induced acute liver injury via alleviating tumor necrosis factor \u03b1-Mediated apoptosis","volume":"44","author":"Yan","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"B133","first-page":"112","article-title":"Analysis of the efficacy of Compound glycyrrhizin injection as an adjuvant treatment for acute jaundice Hepatitis in children","volume":"5","author":"Yang","year":"2020","journal-title":"Smart Health"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e23549","DOI":"10.1002\/jbt.23549","article-title":"Glycyrrhizin protects against diosbulbin B-induced hepatotoxicity by inhibiting the metabolic activation of diosbulbin B","volume":"38","author":"Yang","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s11096-022-01402-x","article-title":"An analysis of the efficacy and safety of compound glycyrrhizin injections in the treatment of drug-induced liver injury using a nationwide database","volume":"44","author":"Yao","year":"2022","journal-title":"Int. J. Clin. Pharm."},{"key":"B136","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.nano.2022.102649","article-title":"Incorporation of glycyrrhizic acid and polyene phosphatidylcholine in lipid nanoparticles ameliorates acute liver injury via delivering p65 siRNA","volume":"48","author":"Yin","year":"2023","journal-title":"Nanomedicine"},{"key":"B137","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/1440-1681.13257","article-title":"The concurrent exposure to aluminium and fructose induces liver injury in rats: protection by monoammonium glycyrrhizinate","volume":"47","author":"Zakaria","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/hep.32651","article-title":"RNA helicase DEAD-box protein 5 alleviates nonalcoholic steatohepatitis progression via tethering TSC complex and suppressing mTORC1 signaling","volume":"77","author":"Zhang","year":"2023","journal-title":"Hepatology"},{"key":"B139","first-page":"448","article-title":"Research progress on mineralocorticoid-like effects of glycyrrhizin and its aglycone glycyrrhetinic acid","volume":"26","author":"Zhang","year":"2011","journal-title":"Drugs & Clin."},{"key":"B140","first-page":"920","article-title":"Efficacy of reduced glutathione combined with compound glycyrrhizin injection in the treatment of alcoholic cirrhosis","volume":"24","author":"Zhang","year":"2023","journal-title":"J. Chronic Dis."},{"key":"B141","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2019.03.014","article-title":"Macrophage p38\u03b1 promotes nutritional steatohepatitis through M1 polarization","volume":"71","author":"Zhang","year":"2019","journal-title":"J. Hepatol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jpha.2022.06.001","article-title":"18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1\/2 in activated HSCs","volume":"12","author":"Zhang","year":"2022","journal-title":"J. Pharm. Anal."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1265172","DOI":"10.3389\/fphar.2023.1265172","article-title":"Advances in the roles of glycyrrhizic acid in cancer therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e71012","DOI":"10.1002\/fsn3.71012","article-title":"Exocarpium Citri Grandis Attenuates lipopolysaccharide-induced acute liver injury through suppression of inflammatory, apoptotic, oxidative, and ferroptotic pathways","volume":"13","author":"Zhang","year":"","journal-title":"Food Sci. Nutr."},{"key":"B145","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/metabo15040263","article-title":"Cellular metabolomics reveals differences in the scope of liver protection between ammonium-based glycyrrhizinate and magnesium isoglycyrrhizinate","volume":"15","author":"Zhang","year":"","journal-title":"Metabolites"},{"key":"B146","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejphar.2017.04.025","article-title":"Diammonium glycyrrhizinate alleviates hepatopulmonary syndrome via restoring superoxide dismutase 3 activity in rats","volume":"807","author":"Zhao","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijbiomac.2020.11.204","article-title":"Glycyrrhizin mediated liver-targeted alginate nanogels delivers quercetin to relieve acute liver failure","volume":"168","author":"Zhao","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"175115","DOI":"10.1016\/j.ejphar.2022.175115","article-title":"Diammonium glycyrrhizinate ameliorates portal hypertension by regulating portal macrophage oxidation and superoxide dismutase 3","volume":"929","author":"Zhao","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1070208","DOI":"10.3389\/fcell.2022.1070208","article-title":"Crosstalk between liver macrophages and gut microbiota: an important component of inflammation-associated liver diseases","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"e35823","DOI":"10.1371\/journal.pone.0035823","article-title":"Diammonium glycyrrhizinate upregulates PGC-1\u03b1 and protects against A\u03b21-42-induced neurotoxicity","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS One"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1795174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:25:38Z","timestamp":1777523138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1795174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":150,"alternative-id":["10.3389\/fphar.2026.1795174"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1795174","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"1795174"}}